Gain Therapeutics Appoints Gene Mack As CFO; Stock Falls
Gain Therapeutics, Inc. (GANX), Monday announced the appointment of Gene Mack as the Chief Financial Officer of the company, effective immediately. Mack will be replacing Evan Ballantyne, who had left the biotechnology company to join Hansa Biopharma (HNSA) in February.
Source: rttnews.com